Acute Effects of Dietary Fiber on Postprandial Responses in Lean and Overweight Subjects
NCT ID: NCT02795559
Last Updated: 2016-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2012-03-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Colonic Short Chain Fatty Acids in Obesity
NCT02562014
Effect of Viscous Soluble Fibres on Body Weight
NCT03257449
Effects of Dietary Fibre on Glucose Metabolism and Satiety
NCT02093481
Short Chain Fatty Acid Metabolism and Energy Metabolism
NCT01826162
Energy -Sensing Metabolites in Caloric Restriction
NCT05031572
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Some studies have shown that overweight people have higher concentrations of SCFA in their stool samples. But the reasons for the difference in stool concentrations of SCFA have not been studied. Stool concentrations of SCFA may differ in lean and overweight people because of differences in type of bacteria in their colons, differences in dietary intakes or maybe because lean and overweight people absorb SCFA produced by bacteria differently.
Therefore, the objectives of this study were to:
1. determine the relationship between SCFA production and the acute effects of consuming an unabsorbed carbohydrate on blood SCFA, FFA, glucose, insulin, c-peptide and gut hormone responses in lean and overweight subjects
2. determine the types of bacteria in the stools of lean and overweight subjects
3. to see if the types of bacteria are correlated with body weight, the composition of the diet, breath gases, fecal SCFA and other demographic and lifestyle factors.
Healthy subjects with a BMI \<25 (lean) or between 25 and 35 (overweight or obese; OWO) took part in a 2 phase study. In phase 1 subjects recorded their dietary intake for 3 days and then provided a stool sample for analysis of micro-organisms and short chain fatty acids. In phase 2 overnight fasted subjects were studied on 3 occasions separated by about a week. On each occasion subjects consumed a control test meal of dextrose, or dextrose plus inulin or dextrose plus resistant start and had breath and blood samples taken at intervals over 4 hours. Subjects were then given a standardized lunch and had more blood and breath samples taken over the next 2 hours.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lean
Subjects within the range of desirable body weight (BMI\<25)
Glucose
75g glucose dissolved in 300ml water
Inulin
75g glucose plus 24g inulin dissolved in 300ml water
Resistant starch
75g glucose plus 28g resistant starch in 300ml water
OWO
Subjects who are overweight or obese (BMI between 25 and 40)
Glucose
75g glucose dissolved in 300ml water
Inulin
75g glucose plus 24g inulin dissolved in 300ml water
Resistant starch
75g glucose plus 28g resistant starch in 300ml water
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glucose
75g glucose dissolved in 300ml water
Inulin
75g glucose plus 24g inulin dissolved in 300ml water
Resistant starch
75g glucose plus 28g resistant starch in 300ml water
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* BMI\<18 or \>39.9
* diabetes
* anaemia
* use of diuretics of beta-blockers
* regular user of antibiotics (≥1 course per year over the last 5 years)
* any use of antibiotics within 3 months
* use of laxatives, weight reducing agents, pre/probiotics or supplements known to influence gastrointestinal function within 3 months
* presence of inflammatory bowel disease, malabsorption, motility disorder, gastrointestinal infection, short bowel, or other condition affecting gastrointestinal function
* liver or kidney disease or major medical or surgical event (within the last 6 months) requiring hospitalization
* high fibre intake (\>30g/day) or other abnormal dietary pattern
* on a weight-loss diet or not on their habitual diet in the two months prior to the study
* unwilling or unable to give informed consent and/or comply with study protocol
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
University of Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Wolever
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas MS Wolever, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glycemic Index Laboratories
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Protocol Reference # 27112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.